Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Adrenergic signaling in cardiomyocytes
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Adrenergic signaling in cardiomyocytes
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Adrenergic signaling in cardiomyocytes
|
Valsartan Valsartan 💬Adrenergic signaling in cardiomyocytes
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬3. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 86 drugs (DrugBank) and 81 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Adrenergic signaling in cardiomyocytes |
Digoxin Digoxin 💬Adrenergic signaling in cardiomyocytes
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬4. Adrenergic signaling in cardiomyocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
AGTR1 1件: AGTR1 💬AGE-RAGE signaling pathway in diabetic complications
|
Valsartan Valsartan 💬AGE-RAGE signaling pathway in diabetic complications
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬5. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Aldosterone synthesis and secretion
|
Valsartan Valsartan 💬Aldosterone synthesis and secretion
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬6. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Aldosterone synthesis and secretion 💬 20 genes, 43 drugs (DrugBank) and 63 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Aldosterone synthesis and secretion |
Digoxin Digoxin 💬Aldosterone synthesis and secretion
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬7. Aldosterone synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Aldosterone-regulated sodium reabsorption |
Digoxin Digoxin 💬Aldosterone-regulated sodium reabsorption
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬8. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
NR3C2 1件: NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Eplerenone Eplerenone 💬Aldosterone-regulated sodium reabsorption
| Eplerenone | 057 5件: 57, 75, 113, 210, 215 💬9. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 34 diseases |
NR3C2 1件: NR3C2 💬Aldosterone-regulated sodium reabsorption
|
Spironolactone Spironolactone 💬Aldosterone-regulated sodium reabsorption
| Spironolactone | 046 12件: 46, 57, 58, 67, 86, 113, 210, 214, 218, 222, 223, 225 💬10. Aldosterone-regulated sodium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
MME 1件: MME 💬Alzheimer disease
|
Sacubitril Sacubitril 💬Alzheimer disease
| Sacubitril | 028 4件: 28, 58, 210, 222 💬11. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PTGS2 1件: PTGS2 💬Alzheimer disease
|
Aspirin Aspirin 💬Alzheimer disease
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Alzheimer disease
|
Colchicine Colchicine 💬Alzheimer disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬13. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
ADRA1A 1件: ADRA1A 💬AMPK signaling pathway
|
Carvedilol Carvedilol 💬AMPK signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬14. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
ADRA1A 1件: ADRA1A 💬AMPK signaling pathway
|
Carvedilol phosphate Carvedilol phosphate 💬AMPK signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬14. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR 1件: HMGCR 💬AMPK signaling pathway
|
Pravastatin sodium Pravastatin sodium 💬AMPK signaling pathway
| Pravastatin | 013 11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR 1件: HMGCR 💬AMPK signaling pathway
|
Pravastatin Pravastatin 💬AMPK signaling pathway
| Pravastatin | 013 11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬16. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Amyotrophic lateral sclerosis
|
Colchicine Colchicine 💬Amyotrophic lateral sclerosis
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬18. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Apelin signaling pathway 💬 18 genes, 37 drugs (DrugBank) and 81 diseases |
AGTR1 1件: AGTR1 💬Apelin signaling pathway
|
Valsartan Valsartan 💬Apelin signaling pathway
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬19. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
PTGS1 2件: PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Arachidonic acid metabolism
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Bile secretion |
Digoxin Digoxin 💬Bile secretion
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬21. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR 1件: HMGCR 💬Bile secretion
|
Pravastatin sodium Pravastatin sodium 💬Bile secretion
| Pravastatin | 013 11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR 1件: HMGCR 💬Bile secretion
|
Pravastatin Pravastatin 💬Bile secretion
| Pravastatin | 013 11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PTGS2 1件: PTGS2 💬C-type lectin receptor signaling pathway
|
Aspirin Aspirin 💬C-type lectin receptor signaling pathway
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Calcium signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Calcium signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬25. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AGTR1 1件: AGTR1 💬Calcium signaling pathway
|
Valsartan Valsartan 💬Calcium signaling pathway
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬27. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
AVPR1A 2件: AVPR1A, AVPR1B 💬
|
Vasopressin Vasopressin 💬Calcium signaling pathway
| Vasopressin | 210 2件: 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA 1件: EDNRA 💬Calcium signaling pathway
|
Ambrisentan Ambrisentan 💬Calcium signaling pathway
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬29. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Calcium signaling pathway
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬32. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬cAMP signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬33. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬cAMP signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬33. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬cAMP signaling pathway |
Digoxin Digoxin 💬cAMP signaling pathway
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬35. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬cAMP signaling pathway
|
Ambrisentan Ambrisentan 💬cAMP signaling pathway
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬36. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬37. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬37. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
EDNRA 1件: EDNRA 💬cAMP signaling pathway
|
Macitentan Macitentan 💬cAMP signaling pathway
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬39. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Carbohydrate digestion and absorption 💬 13 genes, 22 drugs (DrugBank) and 40 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Carbohydrate digestion and absorption |
Digoxin Digoxin 💬Carbohydrate digestion and absorption
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬40. Carbohydrate digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Cardiac muscle contraction 💬 17 genes, 21 drugs (DrugBank) and 34 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Cardiac muscle contraction |
Digoxin Digoxin 💬Cardiac muscle contraction
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬41. Cardiac muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬cGMP-PKG signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬42. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬cGMP-PKG signaling pathway
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬42. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
AGTR1 1件: AGTR1 💬cGMP-PKG signaling pathway
|
Valsartan Valsartan 💬cGMP-PKG signaling pathway
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬44. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬cGMP-PKG signaling pathway |
Digoxin Digoxin 💬cGMP-PKG signaling pathway
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬45. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA 1件: EDNRA 💬cGMP-PKG signaling pathway
|
Ambrisentan Ambrisentan 💬cGMP-PKG signaling pathway
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬46. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬47. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬47. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬cGMP-PKG signaling pathway
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬49. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A 1件: PDE5A 💬cGMP-PKG signaling pathway
|
Sildenafil citrate Sildenafil citrate 💬cGMP-PKG signaling pathway
| Sildenafil | 006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬50. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A 1件: PDE5A 💬cGMP-PKG signaling pathway
|
Sildenafil Sildenafil 💬cGMP-PKG signaling pathway
| Sildenafil | 006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬50. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A 1件: PDE5A 💬cGMP-PKG signaling pathway
|
Tadalafil Tadalafil 💬cGMP-PKG signaling pathway
| Tadalafil | 006 8件: 6 , 51, 75, 77, 84, 86, 113, 210 💬52. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PDE5A 1件: PDE5A 💬cGMP-PKG signaling pathway
|
Udenafil Udenafil 💬cGMP-PKG signaling pathway
| Udenafil | 086 2件: 86, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE 1件: ACE 💬Chagas disease
|
Enalapril maleate Enalapril maleate 💬Chagas disease
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬54. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
ACE 1件: ACE 💬Chagas disease
|
Enalapril Enalapril 💬Chagas disease
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬54. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | Chemical carcinogenesis - DNA adducts 💬 1 gene, 26 drugs (DrugBank) and 43 diseases |
PTGS2 1件: PTGS2 💬Chemical carcinogenesis - DNA adducts
|
Aspirin Aspirin 💬Chemical carcinogenesis - DNA adducts
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Chemical carcinogenesis - receptor activation
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Chemical carcinogenesis - receptor activation
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬57. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Complement and coagulation cascades 💬 21 genes, 46 drugs (DrugBank) and 60 diseases |
F10 1件: F10 💬Complement and coagulation cascades
|
Rivaroxaban Rivaroxaban 💬Complement and coagulation cascades
| Rivaroxaban | 046 10件: 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬59. Complement and coagulation cascades
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE 1件: ACE 💬Coronavirus disease
|
Enalapril maleate Enalapril maleate 💬Coronavirus disease
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬60. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
ACE 1件: ACE 💬Coronavirus disease
|
Enalapril Enalapril 💬Coronavirus disease
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬60. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
AGTR1 1件: AGTR1 💬Coronavirus disease
|
Valsartan Valsartan 💬Coronavirus disease
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬62. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Cortisol synthesis and secretion 💬 15 genes, 39 drugs (DrugBank) and 63 diseases |
AGTR1 1件: AGTR1 💬Cortisol synthesis and secretion
|
Valsartan Valsartan 💬Cortisol synthesis and secretion
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬63. Cortisol synthesis and secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
AGTR1 1件: AGTR1 💬Cushing syndrome
|
Valsartan Valsartan 💬Cushing syndrome
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬64. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Cytoskeleton in muscle cells 💬 26 genes, 19 drugs (DrugBank) and 17 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Cytoskeleton in muscle cells |
Digoxin Digoxin 💬Cytoskeleton in muscle cells
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬65. Cytoskeleton in muscle cells
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Enalapril maleate Enalapril maleate 💬Diabetic cardiomyopathy
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬66. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
ACE 1件: ACE 💬Diabetic cardiomyopathy
|
Enalapril Enalapril 💬Diabetic cardiomyopathy
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬66. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
AGTR1 1件: AGTR1 💬Diabetic cardiomyopathy
|
Valsartan Valsartan 💬Diabetic cardiomyopathy
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬68. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Carvedilol Carvedilol 💬Dilated cardiomyopathy
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬69. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
ADRB1 1件: ADRB1 💬Dilated cardiomyopathy
|
Carvedilol phosphate Carvedilol phosphate 💬Dilated cardiomyopathy
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬69. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
PTGS2 1件: PTGS2 💬Efferocytosis
|
Aspirin Aspirin 💬Efferocytosis
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Endocrine and other factor-regulated calcium reabsorption 💬 9 genes, 31 drugs (DrugBank) and 50 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Endocrine and other factor-regulated calcium reabsorption |
Digoxin Digoxin 💬Endocrine and other factor-regulated calcium reabsorption
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬72. Endocrine and other factor-regulated calcium reabsorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Carvedilol Carvedilol 💬Gap junction
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬73. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
ADRB1 1件: ADRB1 💬Gap junction
|
Carvedilol phosphate Carvedilol phosphate 💬Gap junction
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬73. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Gap junction
|
Colchicine Colchicine 💬Gap junction
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬75. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Gastric acid secretion 💬 14 genes, 54 drugs (DrugBank) and 63 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Gastric acid secretion |
Digoxin Digoxin 💬Gastric acid secretion
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬76. Gastric acid secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
MME 1件: MME 💬Hematopoietic cell lineage
|
Sacubitril Sacubitril 💬Hematopoietic cell lineage
| Sacubitril | 028 4件: 28, 58, 210, 222 💬77. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Hormone signaling
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬78. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Hormone signaling
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬78. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Hormone signaling
|
Valsartan Valsartan 💬Hormone signaling
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬80. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
AVPR1A 3件: AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Hormone signaling
| Vasopressin | 210 2件: 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
THRA 2件: THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Hormone signaling
| Liothyronine | 013 3件: 13, 210, 212 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
THRA 2件: THRA, THRB 💬
|
Liothyronine Liothyronine 💬Hormone signaling
| Liothyronine | 013 3件: 13, 210, 212 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PTGS2 1件: PTGS2 💬Human cytomegalovirus infection
|
Aspirin Aspirin 💬Human cytomegalovirus infection
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
PTGS2 1件: PTGS2 💬Human papillomavirus infection
|
Aspirin Aspirin 💬Human papillomavirus infection
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Huntington disease 💬 26 genes, 42 drugs (DrugBank) and 91 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Huntington disease
|
Colchicine Colchicine 💬Huntington disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬86. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Enalapril maleate Enalapril maleate 💬Hypertrophic cardiomyopathy
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬87. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
ACE 1件: ACE 💬Hypertrophic cardiomyopathy
|
Enalapril Enalapril 💬Hypertrophic cardiomyopathy
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬87. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬IgSF CAM signaling
|
Colchicine Colchicine 💬IgSF CAM signaling
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬89. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
PTGS2 1件: PTGS2 💬IL-17 signaling pathway
|
Aspirin Aspirin 💬IL-17 signaling pathway
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Insulin secretion 💬 16 genes, 51 drugs (DrugBank) and 61 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Insulin secretion |
Digoxin Digoxin 💬Insulin secretion
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬91. Insulin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PTGS2 1件: PTGS2 💬Kaposi sarcoma-associated herpesvirus infection
|
Aspirin Aspirin 💬Kaposi sarcoma-associated herpesvirus infection
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
PTGS2 1件: PTGS2 💬Leishmaniasis
|
Aspirin Aspirin 💬Leishmaniasis
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB 1件: EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬94. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB 1件: EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬94. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
EDNRB 1件: EDNRB 💬Melanogenesis
|
Macitentan Macitentan 💬Melanogenesis
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬96. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
PTGS2 1件: PTGS2 💬MicroRNAs in cancer
|
Aspirin Aspirin 💬MicroRNAs in cancer
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Mineral absorption 💬 8 genes, 14 drugs (DrugBank) and 35 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Mineral absorption |
Digoxin Digoxin 💬Mineral absorption
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬98. Mineral absorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Motor proteins 💬 25 genes, 10 drugs (DrugBank) and 21 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Motor proteins
|
Colchicine Colchicine 💬Motor proteins
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬99. Motor proteins
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Neuroactive ligand signaling
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬100. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 118 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Neuroactive ligand signaling
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬100. Neuroactive ligand signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Neuroactive ligand-receptor interaction
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬102. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Neuroactive ligand-receptor interaction
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬102. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AGTR1 1件: AGTR1 💬Neuroactive ligand-receptor interaction
|
Valsartan Valsartan 💬Neuroactive ligand-receptor interaction
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬104. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
AVPR1A 3件: AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Neuroactive ligand-receptor interaction
| Vasopressin | 210 2件: 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA 1件: EDNRA 💬Neuroactive ligand-receptor interaction
|
Ambrisentan Ambrisentan 💬Neuroactive ligand-receptor interaction
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬106. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬107. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬107. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Neuroactive ligand-receptor interaction
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬109. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTGIR 1件: PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil Treprostinil 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬110. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTGIR 1件: PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬110. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
PTGIR 1件: PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil diolamine Treprostinil diolamine 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬110. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
THRA 2件: THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 3件: 13, 210, 212 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
THRA 2件: THRA, THRB 💬
|
Liothyronine Liothyronine 💬Neuroactive ligand-receptor interaction
| Liothyronine | 013 3件: 13, 210, 212 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
PTGS2 1件: PTGS2 💬NF-kappa B signaling pathway
|
Aspirin Aspirin 💬NF-kappa B signaling pathway
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
PTGS2 1件: PTGS2 💬Ovarian steroidogenesis
|
Aspirin Aspirin 💬Ovarian steroidogenesis
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PTGS2 1件: PTGS2 💬Oxytocin signaling pathway
|
Aspirin Aspirin 💬Oxytocin signaling pathway
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Pancreatic secretion 💬 18 genes, 46 drugs (DrugBank) and 56 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Pancreatic secretion |
Digoxin Digoxin 💬Pancreatic secretion
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬118. Pancreatic secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Parkinson disease 💬 24 genes, 73 drugs (DrugBank) and 71 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Parkinson disease
|
Colchicine Colchicine 💬Parkinson disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬119. Parkinson disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Pathogenic Escherichia coli infection
|
Colchicine Colchicine 💬Pathogenic Escherichia coli infection
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬120. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
AGTR1 1件: AGTR1 💬Pathways in cancer
|
Valsartan Valsartan 💬Pathways in cancer
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬121. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA 1件: EDNRA 💬Pathways in cancer
|
Ambrisentan Ambrisentan 💬Pathways in cancer
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬122. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬123. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬123. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EDNRA 2件: EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Pathways in cancer
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬125. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PTGS2 1件: PTGS2 💬Pathways in cancer
|
Aspirin Aspirin 💬Pathways in cancer
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PTGS2 1件: PTGS2 💬Pathways of neurodegeneration - multiple diseases
|
Aspirin Aspirin 💬Pathways of neurodegeneration - multiple diseases
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Pathways of neurodegeneration - multiple diseases
|
Colchicine Colchicine 💬Pathways of neurodegeneration - multiple diseases
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬128. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Phagocytosis 💬 44 genes, 34 drugs (DrugBank) and 43 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Phagocytosis
|
Colchicine Colchicine 💬Phagocytosis
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬129. Phagocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AGTR1 1件: AGTR1 💬Phospholipase D signaling pathway
|
Valsartan Valsartan 💬Phospholipase D signaling pathway
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬130. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
AVPR1A 3件: AVPR1A, AVPR1B, AVPR2 💬
|
Vasopressin Vasopressin 💬Phospholipase D signaling pathway
| Vasopressin | 210 2件: 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGIR 1件: PTGIR 💬Platelet activation
|
Treprostinil Treprostinil 💬Platelet activation
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬132. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGIR 1件: PTGIR 💬Platelet activation
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Platelet activation
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬132. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGIR 1件: PTGIR 💬Platelet activation
|
Treprostinil diolamine Treprostinil diolamine 💬Platelet activation
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬132. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Platelet activation 💬 24 genes, 72 drugs (DrugBank) and 66 diseases |
PTGS1 1件: PTGS1 💬Platelet activation
|
Aspirin Aspirin 💬Platelet activation
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Prion disease
|
Colchicine Colchicine 💬Prion disease
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬136. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Protein digestion and absorption 💬 15 genes, 12 drugs (DrugBank) and 21 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Protein digestion and absorption |
Digoxin Digoxin 💬Protein digestion and absorption
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬137. Protein digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Protein digestion and absorption 💬 15 genes, 12 drugs (DrugBank) and 21 diseases |
MME 1件: MME 💬Protein digestion and absorption
|
Sacubitril Sacubitril 💬Protein digestion and absorption
| Sacubitril | 028 4件: 28, 58, 210, 222 💬138. Protein digestion and absorption
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Proximal tubule bicarbonate reclamation 💬 7 genes, 6 drugs (DrugBank) and 21 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Proximal tubule bicarbonate reclamation |
Digoxin Digoxin 💬Proximal tubule bicarbonate reclamation
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬139. Proximal tubule bicarbonate reclamation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A 1件: PDE5A 💬Purine metabolism
|
Sildenafil citrate Sildenafil citrate 💬Purine metabolism
| Sildenafil | 006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬140. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A 1件: PDE5A 💬Purine metabolism
|
Sildenafil Sildenafil 💬Purine metabolism
| Sildenafil | 006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬140. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A 1件: PDE5A 💬Purine metabolism
|
Tadalafil Tadalafil 💬Purine metabolism
| Tadalafil | 006 8件: 6 , 51, 75, 77, 84, 86, 113, 210 💬142. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Purine metabolism 💬 30 genes, 44 drugs (DrugBank) and 82 diseases |
PDE5A 1件: PDE5A 💬Purine metabolism
|
Udenafil Udenafil 💬Purine metabolism
| Udenafil | 086 2件: 86, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Regulation of lipolysis in adipocytes
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬144. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Regulation of lipolysis in adipocytes
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬144. Regulation of lipolysis in adipocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Regulation of lipolysis in adipocytes 💬 13 genes, 72 drugs (DrugBank) and 80 diseases |
PTGS1 2件: PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Regulation of lipolysis in adipocytes
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB 1件: EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬147. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB 1件: EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬147. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EDNRB 1件: EDNRB 💬Relaxin signaling pathway
|
Macitentan Macitentan 💬Relaxin signaling pathway
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬149. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE 1件: ACE 💬Renin secretion
|
Enalapril maleate Enalapril maleate 💬Renin secretion
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬150. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ACE 1件: ACE 💬Renin secretion
|
Enalapril Enalapril 💬Renin secretion
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬150. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Renin secretion
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬152. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
ADRB1 2件: ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Renin secretion
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬152. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
AGTR1 1件: AGTR1 💬Renin secretion
|
Valsartan Valsartan 💬Renin secretion
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬154. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA 1件: EDNRA 💬Renin secretion
|
Ambrisentan Ambrisentan 💬Renin secretion
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬155. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA 1件: EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬156. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA 1件: EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬156. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
EDNRA 1件: EDNRA 💬Renin secretion
|
Macitentan Macitentan 💬Renin secretion
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬158. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Enalapril maleate Enalapril maleate 💬Renin-angiotensin system
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬159. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
ACE 1件: ACE 💬Renin-angiotensin system
|
Enalapril Enalapril 💬Renin-angiotensin system
| Enalapril | 013 10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬159. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
AGTR1 1件: AGTR1 💬Renin-angiotensin system
|
Valsartan Valsartan 💬Renin-angiotensin system
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬161. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Renin-angiotensin system 💬 6 genes, 22 drugs (DrugBank) and 33 diseases |
MME 1件: MME 💬Renin-angiotensin system
|
Sacubitril Sacubitril 💬Renin-angiotensin system
| Sacubitril | 028 4件: 28, 58, 210, 222 💬162. Renin-angiotensin system
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Retrograde endocannabinoid signaling 💬 34 genes, 70 drugs (DrugBank) and 74 diseases |
PTGS2 1件: PTGS2 💬Retrograde endocannabinoid signaling
|
Aspirin Aspirin 💬Retrograde endocannabinoid signaling
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol Carvedilol 💬Salivary secretion
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬164. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Salivary secretion
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬164. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | Salivary secretion 💬 20 genes, 75 drugs (DrugBank) and 75 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Salivary secretion |
Digoxin Digoxin 💬Salivary secretion
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬166. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬Salmonella infection
|
Colchicine Colchicine 💬Salmonella infection
| Colchicine | 002 9件: 2 , 42, 46, 50, 56, 93, 97, 210, 266 💬167. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
PTGS1 2件: PTGS1, PTGS2 💬
|
Aspirin Aspirin 💬Serotonergic synapse
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
PTGS2 1件: PTGS2 💬Small cell lung cancer
|
Aspirin Aspirin 💬Small cell lung cancer
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR 1件: HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin sodium Pravastatin sodium 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬170. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR 1件: HMGCR 💬Terpenoid backbone biosynthesis
|
Pravastatin Pravastatin 💬Terpenoid backbone biosynthesis
| Pravastatin | 013 11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬170. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Thyroid hormone signaling pathway |
Digoxin Digoxin 💬Thyroid hormone signaling pathway
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬172. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
THRA 2件: THRA, THRB 💬
|
Liothyronine sodium Liothyronine sodium 💬Thyroid hormone signaling pathway
| Liothyronine | 013 3件: 13, 210, 212 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 174 | Thyroid hormone signaling pathway 💬 25 genes, 46 drugs (DrugBank) and 78 diseases |
THRA 2件: THRA, THRB 💬
|
Liothyronine Liothyronine 💬Thyroid hormone signaling pathway
| Liothyronine | 013 3件: 13, 210, 212 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 175 | Thyroid hormone synthesis 💬 7 genes, 11 drugs (DrugBank) and 11 diseases |
ATP1A1 4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬Thyroid hormone synthesis |
Digoxin Digoxin 💬Thyroid hormone synthesis
| Digoxin | 002 7件: 2 , 8 , 46, 57, 65, 67, 210 💬175. Thyroid hormone synthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 176 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
PTGS2 1件: PTGS2 💬TNF signaling pathway
|
Aspirin Aspirin 💬TNF signaling pathway
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬
|
Carvedilol Carvedilol 💬Vascular smooth muscle contraction
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬177. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬
|
Carvedilol phosphate Carvedilol phosphate 💬Vascular smooth muscle contraction
| Carvedilol | 006 7件: 6 , 46, 57, 58, 86, 113, 210 💬177. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AGTR1 1件: AGTR1 💬Vascular smooth muscle contraction
|
Valsartan Valsartan 💬Vascular smooth muscle contraction
| Valsartan | 028 11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬179. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
AVPR1A 2件: AVPR1A, AVPR1B 💬
|
Vasopressin Vasopressin 💬Vascular smooth muscle contraction
| Vasopressin | 210 2件: 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA 1件: EDNRA 💬Vascular smooth muscle contraction
|
Ambrisentan Ambrisentan 💬Vascular smooth muscle contraction
| Ambrisentan | 051 10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬181. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA 1件: EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬182. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 183 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA 1件: EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 013 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬182. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 184 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
EDNRA 1件: EDNRA 💬Vascular smooth muscle contraction
|
Macitentan Macitentan 💬Vascular smooth muscle contraction
| Macitentan | 051 5件: 51, 85, 86, 88, 210 💬184. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 185 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
PTGIR 1件: PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil Treprostinil 💬Vascular smooth muscle contraction
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬185. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 186 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
PTGIR 1件: PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Vascular smooth muscle contraction
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬185. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Vascular smooth muscle contraction 💬 32 genes, 95 drugs (DrugBank) and 74 diseases |
PTGIR 1件: PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil diolamine Treprostinil diolamine 💬Vascular smooth muscle contraction
| Treprostinil | 051 6件: 51, 84, 85, 86, 88, 210 💬185. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Vasopressin-regulated water reabsorption 💬 1 gene, 6 drugs (DrugBank) and 13 diseases |
AVPR2 1件: AVPR2 💬Vasopressin-regulated water reabsorption
|
Vasopressin Vasopressin 💬Vasopressin-regulated water reabsorption
| Vasopressin | 210 2件: 210, 225 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 189 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PTGS2 1件: PTGS2 💬VEGF signaling pathway
|
Aspirin Aspirin 💬VEGF signaling pathway
| Acetylsalicylic acid | 013 5件: 13, 46, 51, 62, 210 💬
|
Adrenergic signaling in cardiomyocytes
31 genes, 86 drugs (DrugBank) and 81 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Aldosterone synthesis and secretion
20 genes, 43 drugs (DrugBank) and 63 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 34 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Amyotrophic lateral sclerosis
39 genes, 58 drugs (DrugBank) and 116 diseases
Apelin signaling pathway
18 genes, 37 drugs (DrugBank) and 81 diseases
Arachidonic acid metabolism
5 genes, 29 drugs (DrugBank) and 46 diseases
Bile secretion
13 genes, 36 drugs (DrugBank) and 66 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Carbohydrate digestion and absorption
13 genes, 22 drugs (DrugBank) and 40 diseases
Cardiac muscle contraction
17 genes, 21 drugs (DrugBank) and 34 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - DNA adducts
1 gene, 26 drugs (DrugBank) and 43 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Complement and coagulation cascades
21 genes, 46 drugs (DrugBank) and 60 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cortisol synthesis and secretion
15 genes, 39 drugs (DrugBank) and 63 diseases
Cushing syndrome
23 genes, 56 drugs (DrugBank) and 71 diseases
Cytoskeleton in muscle cells
26 genes, 19 drugs (DrugBank) and 17 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Dilated cardiomyopathy
23 genes, 61 drugs (DrugBank) and 93 diseases
Efferocytosis
30 genes, 78 drugs (DrugBank) and 97 diseases
Endocrine and other factor-regulated calcium reabsorption
9 genes, 31 drugs (DrugBank) and 50 diseases
Gap junction
27 genes, 103 drugs (DrugBank) and 87 diseases
Gastric acid secretion
14 genes, 54 drugs (DrugBank) and 63 diseases
Hematopoietic cell lineage
47 genes, 97 drugs (DrugBank) and 101 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Huntington disease
26 genes, 42 drugs (DrugBank) and 91 diseases
Hypertrophic cardiomyopathy
26 genes, 57 drugs (DrugBank) and 97 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
IL-17 signaling pathway
20 genes, 65 drugs (DrugBank) and 91 diseases
Insulin secretion
16 genes, 51 drugs (DrugBank) and 61 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
Melanogenesis
7 genes, 18 drugs (DrugBank) and 34 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
Mineral absorption
8 genes, 14 drugs (DrugBank) and 35 diseases
Motor proteins
25 genes, 10 drugs (DrugBank) and 21 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 118 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
NF-kappa B signaling pathway
23 genes, 81 drugs (DrugBank) and 97 diseases
Ovarian steroidogenesis
7 genes, 40 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Pancreatic secretion
18 genes, 46 drugs (DrugBank) and 56 diseases
Parkinson disease
24 genes, 73 drugs (DrugBank) and 71 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
Phagocytosis
44 genes, 34 drugs (DrugBank) and 43 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
Platelet activation
24 genes, 72 drugs (DrugBank) and 66 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Protein digestion and absorption
15 genes, 12 drugs (DrugBank) and 21 diseases
Proximal tubule bicarbonate reclamation
7 genes, 6 drugs (DrugBank) and 21 diseases
Purine metabolism
30 genes, 44 drugs (DrugBank) and 82 diseases
Regulation of lipolysis in adipocytes
13 genes, 72 drugs (DrugBank) and 80 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Renin-angiotensin system
6 genes, 22 drugs (DrugBank) and 33 diseases
Retrograde endocannabinoid signaling
34 genes, 70 drugs (DrugBank) and 74 diseases
Salivary secretion
20 genes, 75 drugs (DrugBank) and 75 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 62 diseases
Thyroid hormone signaling pathway
25 genes, 46 drugs (DrugBank) and 78 diseases
Thyroid hormone synthesis
7 genes, 11 drugs (DrugBank) and 11 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Vascular smooth muscle contraction
32 genes, 95 drugs (DrugBank) and 74 diseases
Vasopressin-regulated water reabsorption
1 gene, 6 drugs (DrugBank) and 13 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
